Stryker Corporation SYK

272.36 2.61 0.97% as of 25 Sep
Market cap
$103.9B
P/E
28.0×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years

Stryker Corporation (SYK) P/S ratio

As of 25 September 2026, Stryker Corporation (SYK) trades at a P/S ratio of 4.0×. Over the past ten years it has ranged from 3.2× (March 2020) to 6.8× (April 2021); the current reading is higher than 14% of that period. That is above the Medical Devices industry median of 2.7× and above the Healthcare sector median of 3.8×.

P/S ratio, daily

Annual

Period P/S ratio Change
FY2025 5.3× (11.90%)
FY2024 6.1× 10.67%
FY2023 5.5× 8.77%
FY2022 5.0× (14.41%)
FY2021 5.9× (8.09%)
FY2020 6.4× 21.54%
FY2019 5.3× 22.35%
FY2018 4.3× (9.15%)
FY2017 4.7× 20.29%
FY2016 3.9× 12.11%

Quarterly

Period P/S ratio Change
Jun 2026 4.7× (6.14%)
Mar 2026 5.0× (6.91%)
Dec 2025 5.3× (7.75%)
Sep 2025 5.8× (8.67%)
42 more quarters

Against its own ten years

Low 3.2× High 6.8×
Ten-year median 5.1×
Current reading's percentile 14

P/S ratio against peers

Company P/S ratio
PHG Koninklijke Philips N.V. compare 1.2×
GEHC GE HealthCare Technologies Inc. compare 1.4×
MDT Medtronic PLC compare 3.0×
BSX Boston Scientific Corporation compare 3.1×
STE STERIS plc compare 3.4×
ABT Abbott Laboratories compare 3.8×
SYK Stryker Corporation 4.0×
DXCM DexCom, Inc. compare 6.7×
EW Edwards Lifesciences Corporation compare 7.6×
Medical Devices industry median 2.7×
Healthcare sector median 3.8×
Market median 2.0×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

More on SYK